Karyotyping is the gold-standard chromosomal analysis test — providing a complete visual map of all 46 human chromosomes. Using G-Banding technique, chromosomes are stained and photographed under a microscope, allowing detection of numerical abnormalities (extra or missing chromosomes), structural rearrangements (translocations, inversions, deletions), mosaicism, and sex chromosome disorders. It is the first-line diagnostic test for Down syndrome, Turner syndrome, Klinefelter syndrome, and many other chromosomal conditions — confirming diagnoses, guiding treatment, and enabling informed family planning.
Visual G-banded karyotype of all 46 chromosomes — complete picture of chromosome number and structure
Definitive diagnosis of Down syndrome, Turner, Klinefelter, and other chromosomal syndromes
Translocations, inversions, deletions, and duplications visible at chromosomal level
Identify balanced translocations in parents that cause recurrent pregnancy loss
Turner syndrome, Klinefelter, XYY, Triple X, and other sex chromosome abnormalities
If a translocation is found, guides reproductive decisions and risk assessment for future pregnancies
Place your order. Sample collection at a nearby lab is recommended — heparin blood tube required (not standard EDTA).
2–3ml blood in a sodium heparin tube — collected at any pathology lab near you. Heparin is essential for cell culture in karyotyping.
Blood cells are cultured to stimulate division, then arrested at metaphase. Chromosomes stained with Giemsa (G-banding) to reveal characteristic band patterns — analyzed under microscope in our NABL & CAP accredited lab.
Chromosomes photographed, sorted into pairs (karyogram), and analyzed by cytogeneticist. Detailed report in 10–12 days with karyotype image, interpretation, and clinical significance.
A snapshot of your chromosomal analysis report
Complement your karyotype analysis
CMA detects microdeletions and microduplications too small for karyotyping to see — the next step when karyotype is normal but chromosomal cause is still suspected.
For pregnant women — non-invasive prenatal chromosomal screening combining trisomy detection with microdeletion panel. Safe alternative to invasive karyotyping.
When karyotype is normal but a genetic cause is still suspected, WES sequences all 23,000 protein-coding genes for comprehensive rare disease diagnosis.